Lazard Asset Management’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-35,125
Closed -$69.5K 1965
2025
Q4
$69.5K Hold
35,125
﹤0.01% 1779
2025
Q3
$86.4K Buy
35,125
+337
+1% +$868 ﹤0.01% 1703
2025
Q2
$91K Buy
+34,788
New +$93.5K ﹤0.01% 1887
2025
Q1
Sell
-98
Closed 2426
2024
Q4
$0 Hold
98
﹤0.01% 2393
2024
Q3
$0 Sell
98
-172
-64% -$796 ﹤0.01% 2353
2024
Q2
$1K Sell
270
-12,749
-98% -$84.1K ﹤0.01% 2149
2024
Q1
$68K Buy
13,019
+6,593
+103% +$29.9K ﹤0.01% 1653
2023
Q4
$31K Buy
6,426
+259
+4% +$813 ﹤0.01% 2005
2023
Q3
$10K Buy
6,167
+268
+5% +$538 ﹤0.01% 2142
2023
Q2
$16K Buy
+5,899
New +$16.7K ﹤0.01% 2139

Other funds holding IBRX